Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases

Roche (RHHBY) announced that the European Medicines Agency has approved a prefilled syringe (PFS) of the ophthalmology drug Vabysmo (faricimab).The regulatory body approved Vabysmo PFS for use in the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO).In the past three months, shares of Roche have lost 9.1% compared with the industry’s 14.3% decline.Image Source: Zacks Investment ResearchMore on RHHB ...